These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 14638868)

  • 1. Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.
    Shtivelman E
    Mol Cancer Res; 2003 Nov; 1(13):959-69. PubMed ID: 14638868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
    Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
    Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.
    Kang D; Chen J; Wong J; Fang G
    J Cell Biol; 2002 Jan; 156(2):249-59. PubMed ID: 11807090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
    Tsvetkov L; Stern DF
    Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores.
    Ahonen LJ; Kallio MJ; Daum JR; Bolton M; Manke IA; Yaffe MB; Stukenberg PT; Gorbsky GJ
    Curr Biol; 2005 Jun; 15(12):1078-89. PubMed ID: 15964272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHFR-associated early G2/M checkpoint defects in breast cancer cells.
    Erson AE; Petty EM
    Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
    Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
    FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
    Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
    FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.
    Kim JS; Park YY; Park SY; Cho H; Kang D; Cho H
    J Biol Chem; 2011 Sep; 286(35):30615-30623. PubMed ID: 21768102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting in and out of mitosis with Polo-like kinase-1.
    van Vugt MA; Medema RH
    Oncogene; 2005 Apr; 24(17):2844-59. PubMed ID: 15838519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
    Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
    Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
    Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
    Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.
    Mundt KE; Golsteyn RM; Lane HA; Nigg EA
    Biochem Biophys Res Commun; 1997 Oct; 239(2):377-85. PubMed ID: 9344838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry.
    Zou J; Luo SD; Wei YQ; Yang SY
    Mol Biosyst; 2011 Jan; 7(1):169-79. PubMed ID: 20978655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
    Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.
    Jang YJ; Ji JH; Choi YC; Ryu CJ; Ko SY
    J Biol Chem; 2007 Jan; 282(4):2473-82. PubMed ID: 17121863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development.
    Takaki T; Trenz K; Costanzo V; Petronczki M
    Curr Opin Cell Biol; 2008 Dec; 20(6):650-60. PubMed ID: 19000759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia.
    Didier C; Cavelier C; Quaranta M; Demur C; Ducommun B
    Eur J Pharmacol; 2008 Sep; 591(1-3):102-5. PubMed ID: 18616938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage.
    Shang ZF; Huang B; Xu QZ; Zhang SM; Fan R; Liu XD; Wang Y; Zhou PK
    Cancer Res; 2010 May; 70(9):3657-66. PubMed ID: 20406977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.